Characteristics of Patients with Hematologic Malignancies Without Seroconversion Post-COVID19 Third Vaccine Dosing

Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, Yunqi Liao, Michael P. Mullane, Stephen C. Medlin, Kenneth Copeland, James L. Weese
doi: https://doi.org/10.1101/2022.04.07.22273430

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted April 16, 2022.
Download PDF
Data/Code
Email
Characteristics of Patients with Hematologic Malignancies Without Seroconversion Post-COVID19 Third Vaccine Dosing
Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, Yunqi Liao, Michael P. Mullane, Stephen C. Medlin, Kenneth Copeland, James L. Weese
medRxiv 2022.04.07.22273430; doi: https://doi.org/10.1101/2022.04.07.22273430
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area